BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
Marico Ltd.’s Q1 FY22 result was in line with our expectations. Sales momentum continues to remain healthy.
With copra prices sharply declining from their peak in recent months, coupled with price increases taken, the management said gross margin is likely to revive in Q2 before increasing significantly in H2 FY22.
It maintained its strong growth guidance for the foods business, with sales targeted at Rs 5 billion by the end of FY22 and Rs 8.5-10 billion by FY24.
Honey, noodles, and soya chunks are doing very well.
Allied with sales of Rs 5 billion now targeted from e-commerce focused brands by FY24, there is a much required diversification of the portfolio, boosting Marico's medium-to-long term topline growth prospects.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR